Your browser doesn't support javascript.
loading
Development of a competitive binding homogeneous mobility shift assay for the quantification of adalimumab levels in patient serum.
Hock, Barry D; Smith, Stewart M; McEntyre, Christopher J; McKenzie, Judith L; Sies, Christiaan; Keating, Paula E.
Afiliación
  • Hock BD; Haematology Research Group, Christchurch Hospital, Christchurch, New Zealand. Electronic address: barry.hock@otago.ac.nz.
  • Smith SM; Immunology Section, Canterbury Health Laboratories, Christchurch, New Zealand.
  • McEntyre CJ; Specialist Chemistry Section, Canterbury Health Laboratories, Christchurch, New Zealand.
  • McKenzie JL; Haematology Research Group, Christchurch Hospital, Christchurch, New Zealand.
  • Sies C; Specialist Chemistry Section, Canterbury Health Laboratories, Christchurch, New Zealand.
  • Keating PE; Immunology Section, Canterbury Health Laboratories, Christchurch, New Zealand.
J Immunol Methods ; 474: 112672, 2019 11.
Article en En | MEDLINE | ID: mdl-31525368

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Monitoreo de Drogas / Ensayo de Cambio de Movilidad Electroforética / Adalimumab / Inhibidores del Factor de Necrosis Tumoral Tipo de estudio: Prognostic_studies Límite: Humans Idioma: En Revista: J Immunol Methods Año: 2019 Tipo del documento: Article Pais de publicación: Países Bajos

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Monitoreo de Drogas / Ensayo de Cambio de Movilidad Electroforética / Adalimumab / Inhibidores del Factor de Necrosis Tumoral Tipo de estudio: Prognostic_studies Límite: Humans Idioma: En Revista: J Immunol Methods Año: 2019 Tipo del documento: Article Pais de publicación: Países Bajos